Skip to Main Content


Year of Investment:

2017 (and 2008)




Wilmington, MA





Tecomet is a leading provider of high-precision manufacturing solutions for orthopedic implants, as well as critical components for the cardiovascular, medical imaging and aerospace markets. Its core capabilities include forging, casting, precision machining, photochemical etching, welding and finishing. Tecomet has the largest breadth of offerings among orthopedic outsourced manufacturers and deep partnerships with many blue-chip customers, including some of the nation’s leading medical and aerospace & defense OEMs.

Charlesbank Investment

The May 2017 transaction marked Charlesbank’s second acquisition of Tecomet, both times in partnership with management. Charlesbank first purchased the company in a complex corporate carve-out in 2008, expanding its business capabilities, customer base and reputation for innovation before selling it in late 2013.


Victor Swint


Bill Dow



Key Team Members
Related News
January 28, 2019

Victor Swint Named Tecomet CEO, Succeeds Interim CEO Bill Dow

Tecomet, a leading contract manufacturer of orthopedic implants, instruments and sterilization cases, announced the appointment of Victor Swint as its… Read More

May 1, 2017

Charlesbank Capital Partners Acquires Tecomet, for second time

BOSTON, MA, MAY 2, 2017 – Charlesbank Capital Partners, LLC today announced the acquisition of Tecomet. Based in Wilmington, MA,… Read More

December 18, 2013

Tecomet, a Portfolio Company of Charlesbank Capital Partners, Acquired by Genstar

Tecomet, a portfolio company of Charlesbank Capital Partners, announced today that it has been acquired by Genstar Capital. The terms… Read More

Additional Healthcare Portfolio Companies